Sign up to save your podcasts
Or
Share 109: Aurobindo's US outlook improves but earnings may just be steady
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
109: Aurobindo's US outlook improves but earnings may just be steady
Investors are banking on Aurobindo’s US pharma revenues getting a boost on the back of improving injectable sales in the second quarter. But a part of that growth already seems to be reflecting in the stock price gains of about 86% in 2020. Find more details in this podcast. Listen in.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Mint - HT SmartcastInvestors are banking on Aurobindo’s US pharma revenues getting a boost on the back of improving injectable sales in the second quarter. But a part of that growth already seems to be reflecting in the stock price gains of about 86% in 2020. Find more details in this podcast. Listen in.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Mark to Market
View all
Metro Matters
0 Listeners
ReSized
0 Listeners
Health And Tonic
0 Listeners
Mint Evening Market Wrap
0 Listeners
Healthwise
0 Listeners
Parenting ke Pal
0 Listeners
The Final Whistle
0 Listeners
Mint Lite Morning Shot
0 Listeners
WhatsApp University: Jhakaas ya Bakwaas!
0 Listeners
Kadak Chai
0 Listeners
Crima Facie
0 Listeners
Top of the Morning
4 Listeners
HT AutoNation
0 Listeners
F wala Pyaar
0 Listeners
Crypto Current
0 Listeners
Bagga Paaji Di Policy
0 Listeners
HT Culture Curry
0 Listeners
The Sketch
0 Listeners
The Fever Folk Project
0 Listeners
Now You Know
0 Listeners